• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Codes Crack (1135); Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/29/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported by nurse ¿patient had the device inserted on (b)(6) 2022 and left over night for treatment.When the nurse went to flush the line on (b)(6), there was leaking out of the tubing, no type of harm involved.".
 
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of asgnf076 showed no other similar product complaint(s) from this lot number.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, complaint and lot history review, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leak is confirmed and was determined to be supplier related.Two 19 g x 0.75 in.Powerloc max infusion sets with non-valved y-sites were returned for evaluation.An initial visual observation showed use residue on one sample and the other sample was returned in a sealed package.Needleless injection caps were returned on both luer hubs of the used sample, and the safety mechanism of this sample was observed to be engaged.A large longitudinal crack was observed in the y-site of the used sample between the two branches of the y-site on the larger branch.A microscopic observation revealed a distinct knit/weld line in the y-site of the sample returned in a sealed package.Micro-fractures were observed in the used sample around the large crack in the y-site.The device is a supplied component, and the supplier has been notified of this event.H3 other text : evaluation findings are in section h.11.
 
Event or Problem Description
It was reported by nurse ¿patient had the device inserted on (b)(6) 2022 and left over night for treatment.When the nurse went to flush the line on (b)(6), there was leaking out of the tubing, no type of harm involved.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
kayla olsen
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15065113
Report Number3006260740-2022-02807
Device Sequence Number5529991
Product Code FPA
UDI-Device Identifier00801741047343
UDI-Public(01)00801741047343
Combination Product (Y/N)N
Initial Reporter StateMT
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0131975
Device Lot NumberASGNF076
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/01/2022
Supplement Date Received by Manufacturer09/21/2022
Initial Report FDA Received Date07/20/2022
Supplement Report FDA Received Date09/24/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/01/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-